🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the producers of Tylenol, alleging the companies withheld alleged dangers that the drug created to children's neurological development.

This legal action arrives a month after Donald Trump promoted an unsubstantiated connection between using Tylenol - referred to as acetaminophen - while pregnant and autism in children.

Paxton is filing suit against J&J, which once produced the medication, the only pain reliever suggested for expectant mothers, and the current manufacturer, which presently makes it.

In a statement, he claimed they "misled consumers by profiting off of suffering and marketing drugs regardless of the potential hazards."

The company asserts there is lacking scientific proof tying acetaminophen to autism.

"These corporations lied for decades, deliberately risking numerous people to increase profits," Paxton, from the Republican party, declared.

The company said in a statement that it was "seriously troubled by the dissemination of inaccurate information on the reliability of acetaminophen and the possible consequences that could have on the welfare of US mothers and children."

On its online platform, the company also said it had "regularly reviewed the pertinent research and there is lacking reliable evidence that demonstrates a established connection between using acetaminophen and autism spectrum disorder."

Groups acting on behalf of medical professionals and health professionals share this view.

ACOG has said paracetamol - the primary component in acetaminophen - is among limited choices for pregnant women to address discomfort and elevated temperature, which can create significant medical dangers if left untreated.

"In over twenty years of investigation on the utilization of acetaminophen in gestation, zero credible investigations has successfully concluded that the usage of acetaminophen in any period of pregnancy causes brain development issues in offspring," the association stated.

This legal action cites recent announcements from the Trump administration in asserting the medication is potentially dangerous.

Recently, the former president raised alarms from medical authorities when he advised women during pregnancy to "struggle intensely" not to use acetaminophen when ill.

Federal regulators then released a statement that physicians should think about restricting the usage of acetaminophen, while also mentioning that "a causal relationship" between the medication and autism in young ones has remains unverified.

Health Secretary Kennedy, who manages the FDA, had promised in April to conduct "extensive scientific investigation" that would establish the cause of autism spectrum disorder in a limited time.

But experts warned that finding a single cause of autism spectrum disorder - thought by researchers to be the result of a complicated interplay of inherited and surrounding conditions - would prove challenging.

Autism is a category of permanent neurological difference and impairment that affects how individuals experience and relate to the surroundings, and is diagnosed using doctors' observations.

In his legal document, Paxton - a Trump ally who is seeking US Senate - claims the manufacturer and J&J "deliberately disregarded and attempted to silence the science" around acetaminophen and autism spectrum disorder.

This legal action seeks to make the companies "remove any commercial messaging" that states acetaminophen is reliable for women during pregnancy.

This legal action parallels the concerns of a assembly of parents of young ones with autism spectrum disorder and ADHD who sued the makers of Tylenol in 2022.

Judicial authorities dismissed the case, declaring investigations from the parents' expert witnesses was inconclusive.